A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

  1. van Brummelen, E.M.J.
  2. Levchenko, E.
  3. Dómine, M.
  4. Fennell, D.A.
  5. Kindler, H.L.
  6. Viteri, S.
  7. Gadgeel, S.
  8. López, P.G.
  9. Kostorov, V.
  10. Morgensztern, D.
  11. Orlov, S.
  12. Zauderer, M.G.
  13. Vansteenkiste, J.F.
  14. Baker-Neblett, K.
  15. Vasquez, J.
  16. Wang, X.
  17. Bellovin, D.I.
  18. Schellens, J.H.M.
  19. Yan, L.
  20. Mitrica, I.
  21. DeYoung, M.P.
  22. Trigo, J.
Aldizkaria:
Investigational New Drugs

ISSN: 1573-0646 0167-6997

Argitalpen urtea: 2020

Alea: 38

Zenbakia: 2

Orrialdeak: 457-467

Mota: Artikulua

DOI: 10.1007/S10637-019-00783-7 GOOGLE SCHOLAR